Singapore markets close in 2 hours 49 minutes
Straits Times Index
3,284.07 -3.68 (-0.11%) Nikkei
37,960.09 +331.61 (+0.88%) Hang Seng
17,728.83 +444.29 (+2.57%) FTSE 100
8,078.86 +38.48 (+0.48%) Bitcoin USD
64,482.71 +229.83 (+0.36%) CMC Crypto 200
1,392.50 -4.03 (-0.29%)
Astria Therapeutics, Inc. (ATXS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 503.55M |
| Enterprise value | 352.68M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 3.41 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -5.20 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.71 |
| 52-week change 3 | -29.73% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 16.90 |
| 52-week low 3 | 4.26 |
| 50-day moving average 3 | 13.11 |
| 200-day moving average 3 | 9.00 |
Share statistics
| Avg vol (3-month) 3 | 1.05M |
| Avg vol (10-day) 3 | 789.38k |
| Shares outstanding 5 | 54.91M |
| Implied shares outstanding 6 | 58.76M |
| Float 8 | 36.14M |
| % held by insiders 1 | 0.49% |
| % held by institutions 1 | 87.93% |
| Shares short (15 Apr 2024) 4 | 5.05M |
| Short ratio (15 Apr 2024) 4 | 3.32 |
| Short % of float (15 Apr 2024) 4 | 9.55% |
| Short % of shares outstanding (15 Apr 2024) 4 | 9.19% |
| Shares short (prior month 15 Mar 2024) 4 | 2.01M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 31 Dec 2018 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 20 Aug 2021 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -17.47% |
| Return on equity (ttm) | -31.40% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -72.89M |
| Diluted EPS (ttm) | -2.42 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 246.53M |
| Total cash per share (mrq) | 4.49 |
| Total debt (mrq) | 329k |
| Total debt/equity (mrq) | 0.14% |
| Current ratio (mrq) | 21.73 |
| Book value per share (mrq) | 3.60 |
Cash flow statement
| Operating cash flow (ttm) | -68.44M |
| Levered free cash flow (ttm) | -36.52M |
© 2024 Yahoo. All rights reserved.